<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js"> <!--<![endif]-->
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <meta name="description" content="Bingo One page parallax responsive HTML Template ">

    <title>癌症热点分析</title>
    <!-- Mobile Specific Meta
      ================================================== -->
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <!-- Favicon -->
    <!-- CSS
    ================================================== -->
    <!-- Themefisher Icon font -->
    <link rel="stylesheet" href="plugins/themefisher-font/style.css">
    <!-- bootstrap.min css -->
    <link rel="stylesheet" href="plugins/bootstrap/dist/css/bootstrap.min.css">
    <!-- Lightbox.min css -->
    <link rel="stylesheet" href="plugins/lightbox2/dist/css/lightbox.min.css">
    <!-- Slick Carousel -->
    <link rel="stylesheet" href="plugins/slick-carousel/slick/slick.css">
    <link rel="stylesheet" href="plugins/slick-carousel/slick/slick-theme.css">
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="css/style.css">

</head>
<body id="body">
<!--
 Start Preloader
 ==================================== -->
<div id="preloader">
    <div class="preloader">
        <div class="sk-circle1 sk-child"></div>
        <div class="sk-circle2 sk-child"></div>
        <div class="sk-circle3 sk-child"></div>
        <div class="sk-circle4 sk-child"></div>
        <div class="sk-circle5 sk-child"></div>
        <div class="sk-circle6 sk-child"></div>
        <div class="sk-circle7 sk-child"></div>
        <div class="sk-circle8 sk-child"></div>
        <div class="sk-circle9 sk-child"></div>
        <div class="sk-circle10 sk-child"></div>
        <div class="sk-circle11 sk-child"></div>
        <div class="sk-circle12 sk-child"></div>
    </div>
</div>

<section class="service-list section bg-gray">
    <div class="container">
        <div class="row">
            <div class="col">
                <div class="title text-center">
                    <h2>癌症热点分析</h2>
                    <span class="border"></span>
                    <p>数据来源于pubmed，选取关键词为cancer和clinical，其中cancer必须在title中出现</p>
                    <p>2019年论文截止至7月1日</p>
                </div>
            </div>
        </div>
        <div class="row">
            <div class="col-md-3">
                <div class="block">
                    <i class="tf-ion-ios-book-outline"></i>
                    <h3>2016</h3>
                    <ul>
                        <li>共10158篇</li>
                        <li>乳腺癌占比17.0%</li>
                        <li>肺癌占比11.2%</li>
                        <li>大肠癌占比8.6%</li>
                    </ul>
                </div>
            </div>
            <div class="col-md-3">
                <div class="block">
                    <i class="tf-ion-ios-book-outline"></i>
                    <h3>2017</h3>
                    <ul>
                        <li>共18631篇</li>
                        <li>乳腺癌占比19.9%</li>
                        <li>肺癌占比14.0%</li>
                        <li>大肠癌占比9.0%</li>
                    </ul>
                </div>
            </div>
            <div class="col-md-3">
                <div class="block">
                    <i class="tf-ion-ios-book-outline"></i>
                    <h3>2018</h3>
                    <ul>
                        <li>共24874篇</li>
                        <li>乳腺癌占比19.7%</li>
                        <li>肺癌占比13.6%</li>
                        <li>大肠癌占比9.4%</li>
                    </ul>
                </div>
            </div>
            <div class="col-md-3">
                <div class="block">
                    <i class="tf-ion-ios-book-outline"></i>
                    <h3>2019</h3>
                    <ul>
                        <li>共13937篇</li>
                        <li>乳腺癌占比19.2%</li>
                        <li>肺癌占比13.4%</li>
                        <li>大肠癌占比9.6%</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>
</section>

<section class="section">
    <div class="container">
        <h2>详细信息</h2>
        <div class="row">
            <div class="col-md-4 align-self-start">
                <p>
                <p>TUSC3 functional duality of a cancer gene Two decades ago following a systematic screening of LOH regions on chromosome 8p22 TUSC3 has been identified as a candidate tumor suppressor gene in ovarian prostate and pancreatic cancers Since then a growing body of evidence documented its clinical importance in various other types of cancers and first initial insights into its molecular function and phenotypic effects have been gained though the precise role of TUSC3 in different cancers remains unclear As a part of the oligosaccharyltransferase complex TUSC3 localizes to the endoplasmic reticulum and functions in final steps of Nglycosylation of proteins while its loss evokes the unfolded protein response We are still trying to figure out how this mechanistic function is reconcilable with its varied effects on cancer promotion In this review we focus on cancerrelated effects of TUSC3 and envisage a possible role of TUSC3 beyond endoplasmic reticulum</p>
            </div>
            <div class="col-md-4 align-self-start">
                <p>Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer Patients with nonmetastatic esophageal cancer not suitable for surgery can be treated with definitive chemoradiotherapy with curative intent The purpose of this retrospective study is to evaluate the clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel Medical records were reviewed of patients treated for nonmetastatic squamous cell or adenocarcinoma of the esophagus between January 2009 and December 2013 in two collaborating institutes Treatment consisted of external beam radiotherapy 28 fractions of 18 Gy and 6 weekly courses of carboplatin AUC  2 and paclitaxel 50 mgm2 Data on survival progression toxicity and effect on dysphagia were recorded Sixtysix patients were included Median overall survival OS was 131 months 95 CI 47215 months and a 2year OS was 30 95 CI 1842 At 2 years 26 of patients developed local progression 95 CI 1537 and 49 developed distant metastases 95 CI 3664 Acute toxicity grade 3 was observed in 47 of patients Late adverse events grade 3 were seen in 20 mostly esophageal stenoses Of patients with available data 3 months after treatment 70 had relief of dysphagia Definitive chemoradiotherapy led to a median OS of 13 months Toxicity was common mostly due to hematological toxicity Given the relatively short median survival an adequate selection of patients for this intensive treatment is required</p>
            </div>
            <div class="col-md-4 align-self-start">
                <p>How to evaluate and assess quality of life issues in head and neck cancer patients PURPOSE OF REVIEW Review quality of life QOL concepts and most common instruments to be used in patients with head and neck cancer as well as the potential benefits and limitations of information derived from QOL studies RECENT FINDINGS Information from QOL studies can be clinical predictors of prognosis serve as potential screening and planning tools for clinical care and rehabilitation efforts Enhancements in computer technology and the advent of tools like head and neck cancerspecific item prompt list will allow for QOL data to be used more easily SUMMARY Patients with malignant head and neck neoplasms can present changes in important vital functions related to the disease and its treatment usually resulting in a negative impact on their QOL The application of specific questionnaires can be used to measure such impact and the information derived from QOL studies has the potential to be incorporated in the clinical practice to improve the quality of care</p>
            </div>
        </div>
    </div>
</section>
<!--
Essential Scripts
=====================================-->
<!-- Main jQuery -->
<script src="plugins/jquery/dist/jquery.min.js"></script>
<!-- Bootstrap 3.7 -->
<script src="plugins/bootstrap/dist/js/popper.min.js"></script>
<script src="plugins/bootstrap/dist/js/bootstrap.min.js"></script>
<!-- Parallax -->
<script src="plugins/parallax/jquery.parallax-1.1.3.js"></script>
<!-- lightbox -->
<script src="plugins/lightbox2/dist/js/lightbox.min.js"></script>
<!-- Owl Carousel -->
<script src="plugins/slick-carousel/slick/slick.min.js"></script>
<!-- Portfolio Filtering -->
<script src="plugins/mixitup/dist/mixitup.min.js"></script>
<!-- Smooth Scroll js -->
<script src="plugins/smooth-scroll/dist/js/smooth-scroll.min.js"></script>
<!-- Custom js -->
<script src="js/script.js"></script>

</body>
</html>